SCHEMBL3492989

SCHEMBL3492989

OCCNc1ccccc1CCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
GLA P06280 2/20 0.47
MAPK1 P28482 1/20 0.42
ALDH1A1 P00352 3/20 0.41
GAA P10253 3/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
RECQL P46063 2/20 0.40
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
CYP2C19 P33261 1/20 0.39
POLB P06746 2/20 0.39
MITF O75030 1/20 0.39
LMNA P02545 1/20 0.39
TTR P02766 1/20 0.39
RAD52 P43351 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11455284 0.86 KDM4E (0.47) KDM4EGLAMAPK1ALDH1A1GAA
SCHEMBL9177752 0.85 ALDH1A1 (0.56) KDM4EALDH1A1GAAMAPTHPGD
Water SCHEMBL11410514 0.83 KDM4E (0.47) KDM4EGLAMAPK1ALDH1A1GAA
SCHEMBL202398 0.82 GAA (0.36) KDM4EGLAALDH1A1GAAMAPT
SCHEMBL6156472 0.82 KDM4E (0.57) KDM4EGLAMAPK1ALDH1A1GAA
SCHEMBL8283681 0.82 MEN1 (0.43) KDM4EGLAALDH1A1GAAMAPT
SCHEMBL370882 0.82 KDM4E (0.54) KDM4EGLAALDH1A1GAAMAPT
SCHEMBL12021302 0.82 KDM4E (0.46) KDM4EGLAMAPK1ALDH1A1GAA
SCHEMBL31310613 0.81 KDM4E (0.44) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL15994064 0.79 MAOB (0.43) GAARAB9ATDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630663-B2 Aqueous polyurethane resin dispersion AGFA NV (BE) 2026-05-19 US disclosed
EP-4165097-B1 AQUEOUS POLYURETHANE RESIN DISPERSION AGFA NV (BE) 2024-03-20 EP disclosed
US-11802205-B2 Aqueous polyurethane resin dispersion AGFA NV (BE) 2023-10-31 US disclosed
US-20230220145-A1 Aqueous Polyurethane Resin Dispersion AGFA NV (BE) 2023-07-13 US disclosed
EP-4165097-A1 AQUEOUS POLYURETHANE RESIN DISPERSION AGFA NV (BE) 2023-04-19 EP disclosed
US-11542393-B2 Radiation curable polyurethane resin for ink jet ink AGFA NV (BE) 2023-01-03 US disclosed
US-20200369880-A1 RADIATION CURABLE POLYURETHANE RESIN FOR INK JET INK AGFA NV (BE) 2020-11-26 US disclosed
EP-3717540-A1 RADIATION CURABLE POLYURETHANE RESIN FOR INK JET INK AGFA NV (BE) 2020-10-07 EP disclosed
US-7749678-B2 contains sulfonium compound; improved line edge roughness and pattern profile, and contrast of sensitivity and dissolution in extreme ultraviolet exposure FUJIFILM CORPORATION (JP) 2010-07-06 US disclosed
EP-1966132-A2 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-09-10 EP disclosed
WO-2008048914-A1 POLYCYCLIC COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-04-24 WO disclosed
WO-2007070760-A2 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-21 WO disclosed
US-20050233242-A1 Photosensitive composition and pattern forming method using the same FUJI PHOTO FILM CO., LTD. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630663-B2 Aqueous polyurethane resin dispersion PUF60, PCMT1, EED KDM4E 499/4885GLA 4842/4885MAPK1 1443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.